Real-time enrollment status for this gastric or gastro-esophageal junction (gej) adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:04 PM UTC
| NCT Number | NCT07488676 |
| Recruiting Status | Recruiting |
| Condition | Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 150 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | September 22, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT07488676 is currently recruiting participants. This phase1 study for gastric or gastro-esophageal junction (gej) adenocarcinoma is actively seeking new participants at 18 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07488676 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07488676 was last updated 2 weeks ago (September 22, 2026). HelloStudys verifies this status automatically.